Provided by Tiger Trade Technology Pte. Ltd.

Carlisle

344.81
+2.120.62%
Post-market: 344.810.00000.00%17:30 EDT
Volume:630.83K
Turnover:217.76M
Market Cap:13.95B
PE:20.14
High:349.15
Open:342.21
Low:340.26
Close:342.69
52wk High:435.92
52wk Low:293.43
Shares:40.47M
Float Shares:39.96M
Volume Ratio:2.17
T/O Rate:1.58%
Dividend:4.30
Dividend Rate:1.25%
EPS(TTM):17.12
EPS(LYR):17.12
ROE:38.23%
ROA:10.88%
PB:8.44
PE(LYR):20.14

Loading ...

Analysts Are Neutral on These Healthcare Stocks: CSL (CMXHF), ONO Pharmaceutical Co (OPHLF)

TIPRANKS
·
28 mins ago

Buccaneer Energy publishes 2025 annual report

Reuters
·
May 29

CSL's Ex-Bull Worries About Intensifying Competition to Vifor -- Market Talk

Dow Jones
·
May 29

CSL Says CEO Indirectly Acquires Nearly AU$108,000 Worth of Shares

MT Newswires Live
·
May 28

CSL (CMXHF) Receives a Buy from Morgan Stanley

TIPRANKS
·
May 26

Is Carlisle Companies (CSL) Offering Value After Recent Share Price Pullback?

Simply Wall St.
·
May 24

The Bull Case For CSL (ASX:CSL) Could Change Following Canadian HEMGENIX Reimbursement Milestone – Learn Why

Simply Wall St.
·
May 20

A Look At Carlisle Companies (CSL) Valuation After Recent Share Price Weakness

Simply Wall St.
·
May 17

Assessing CSL (ASX:CSL) Valuation After Interim CEO Review And Financial Update

Simply Wall St.
·
May 16

Citi Sticks to Its Hold Rating for CSL (CMXHF)

TIPRANKS
·
May 15

CSL Enters Agreement to Boost Influenza Pandemic Preparedness in Latin America, Caribbean

MT Newswires Live
·
May 13

Jarden downgrades CSL (CMXHF) to a Hold

TIPRANKS
·
May 13

Canaccord Genuity downgrades CSL (CMXHF) to a Hold

TIPRANKS
·
May 13

Australia R&D Changes Look Positive for CSL, Others -- Market Talk

Dow Jones
·
May 13

Analysts Conflicted on These Healthcare Names: CSL (OtherCMXHF) and Tilray (TLRY)

TIPRANKS
·
May 12

Ord Minnett Keeps Their Hold Rating on CSL (CMXHF)

TIPRANKS
·
May 12

Morgan Stanley Reaffirms Their Buy Rating on CSL (CMXHF)

TIPRANKS
·
May 12

CSL (CMXHF) Receives a Hold from Bell Potter

TIPRANKS
·
May 12

CSL's Revenue, Profit Guidance Downgrade Worse Than Anticipated -- Market Talk

Dow Jones
·
May 12

CSL's Profit, Revenue Downgrade 'Not a Complete Surprise' -- Market Talk

Dow Jones
·
May 12